Use of nitric oxide in acute respiratory failure

Clinical Pulmonary Medicine

Volumn 6, Issue 3, 1999, Pages 187-194

  Rovira, Irene ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hypoxemia; Inhalation; Nitric oxide; Pulmonary hypertension; Respiratory failure; Ventilation perfusion relationship

Indexed keywords

NITRIC OXIDE;

ACUTE RESPIRATORY FAILURE; ANTIINFLAMMATORY ACTIVITY; CLINICAL FEATURE; DRUG EFFECT; DRUG SAFETY; HEART FAILURE; HUMAN; HYPOXEMIA; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG TOXICITY; PULMONARY HYPERTENSION; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT CONTRAINDICATION; VASODILATATION;

EID: 0032926762     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199905000-00005     Document Type: Review

References (70)

1. Culotta E, Kosland DE Jr. Molecule of the year. NO news is good news. Science 1992;258: 1862-5.
2. Moncada M, Palmer MRJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-41.
3. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149:538-51.
4. Palmer RMJ, Ferriage AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
5. Ignarro LJ, Buga GM, Wood KS, Byrns RP, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and veins is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9.
6. Brunton TL. Use of nitrite of amyl in angina pectoris. Lancet 1867;2:97-8.
7. Reefer LK, Nims RW, Davies KM, Wink DA. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 1996;268:281-93.
8. Borland CD, Higenbottam TW. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide. Eur Respir J 1989;2:56-63.
9. Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Couts C, Wallwork J. Inhaled "endothelium derived relaxing factor" in primary pulmonary hypertension [abstract]. Am Rev Respir Dis 1988;173(Suppl 4):A107.
10. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83: 2038-47.
11. Rovira I, Chen TY, Winkler M, Kawai N, Block KD, Zapol WM. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 1994;76:345-55.
12. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone A, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991;338: 1173-4.
13. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340: 818-9.
14. Roissant R, Falke KJ, Keitel M, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
15. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89:2035-40.
16. Fostell C, Blomqvist H, Hedenstierna G, Lunberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78.427-35.
17. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993;88: 2884-7.
18. Bigatello LM, Hurford WE, Kacmareck RM, Roberts JD, Zapol WM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994; 80:761-70.
19. Puibasset L, Rouby JJ, Mourgeon E, et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994;20:319-27.
20. Gerlach H, Roissant R, Pappert D, Falke KJ. Time course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993;23:499-502.
21. Fierobe L, Brunet F, Dhainaut JF, Monchi M, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:1414-9.
22. Roissant R, Slama K, Steudel W, et al. Effect of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med 1995;21:612-3.
23. Puybasset L, Stewart T, Rouby JJ, et al. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 1994;80:1254-67.
24. Roissant R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995;107:1107-15.
25. Treggiary-Venzi M, Ricou B, Romand JA, Suter PM. The response to repeated nitric oxide inhalation is inconsistent in patients with acute respiratory distress syndrome. Anesthesiology 1998;88:634-41.
26. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157:1372-80.
27. Manktelow C, Bigatello LM, Hess D, Hurford WE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1997;87:297-307.
28. Puybasset L, Rouby JJ, Mourgeon E, et al. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 1995;152: 318-28.
29. Putensen C, Rasanen J, Lopez FA, Downs JB. Continuous positive airway pressure modulates effect of inhaled nitric oxide on ventilation-perfusion distributions in canine lung injury. Chest 1994;106:1563-9.
30. Gómez FP, Iglesia R, Torres A, et al. Nitric oxide inhalation in severe pneumonia [abstract]. Eur Respir J 1997;10:21S.
31. Kemming GI, Merkel MJ, Schallerer A, et al. Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation. Intensive Care Med 1998;24:1173-80.
32. Wysocki M, Delclaux C, Roupi E, et al. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 1994;20:254-9.
33. Lu Q, Mourgeon E, Law-Koune JD, et al. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome. Anesthesiology 1995; 83:929-43.
34. Ichinose F, Adrie C, Hurford WE, Zapol WM. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. J Appl Physiol 1995;78:1288-95.
35. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide [letter]. Lancet 1995;346: 647-8.
36. Doering EB, Hanson CW, Reily DJ, Marshall C, Marshall BE. Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 1997;87:18-25.
37. Papazian L, Bregeon F, Gaillat F, et al. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome. Am J Rev Respir Crit Care Med 1998;157:580-5.
38. Houmes RJM, Hartog A, Verbrugge SJC, Bohm S, Lachman B. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury. Intensive Care Med 1997;23:163-9.
39. Zhu GF, Sun B, Niu SF, et al. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:437-43.
40. Dellinger RF, Zimmerman JL, Taylor R, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998;26:15-23.
41. Buga GM, Gold ME, Wood KS, Chaudhuri G, Ignarro LJ. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol 1989;161:61-72.
42. Belvisi MG, Stretton CD, Yacoub M, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992;210:221-2.
43. Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM. Bronchodilator action of inhaled nitric oxide in guinea pig. J Clin Invest 1992;90:421-8.
44. Hogman M, Frostell CG, Hedenstrom H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993;148:1474-8.
45. Roger N, Barbera JA, Farre R, Cobos A, Roca J, Rodriguez-Roisin R. Effect of nitric oxide inhalation on respiratory system resistance in chronic obstructive pulmonary disease. Eur Respir J 1996;9:190-5.
46. Kackmareck RM, Ripple R, Cockrill BA, et al. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am Rev Respir Crit Care Med 1996; 153:128-35.
47. Kharitonow SA, Yates D, Robbins RA, Logan-Synclair R, Shinebourne EA, Barnes JP. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
48. Gómez FP, Barbera JA, Roca J, et al. Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma. Eur Respir J 1998; 12:865-71.
49. A/Q distributions during inhalation of nitric oxide in pigs with methacholine-induced bronchoconstriction. Am J Respir Crit Care Med 1995;151:116-22.
50. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-5.
51. Bloomfield GL, Holloway S, Ridings PC, et al. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997;25:584-93.
52. Benzing A, Brautigam P, Geiger K, Loop T, Beyer U, Moser E. Inhaled nitric oxide reduced pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 1995;83:1153-61.
53. Chollet-Martin S, Gatacel C, Kermarrec N, Gougerot-Pocidalo MA, Payen DM. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996;153:985-90.
54. Shah NS, Nakayama DK, Jacob TD, et al. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg 1994;129:158-64.
55. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamics effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24: 982-8.
56. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-5.
57. Rovira I, Fita G, Basora M, et al. Effects of inhaled nitric oxide in cardiac surgical patients with pulmonary hypertension and heart failure [abstract]. Intensive Care Med 1997;23:S78.
58. Benzing A, Mois G, Beyer U, Geiger K. Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide. Acta Anaesthesiol. Scand 1997;41:643-6.
59. Troncy E, Francoeur M, Salazkin Y, Vinay J. Blaise GA. Systemic effect of inhaled nitrioxide: modification of renal hemodynamic pigs. In: Moncda S, Stamler J, Gross S, Higgs EA, editors. The biology of nitric oxide. Part 5 London: Portland Press, 1996:319-323.
60. Stamler JS, Jaraki O, Osborne J, et al. Nitrioxide circulates in mammalian plasma prjm ily as an S-nitroso adduct of serum albumin Proc Natl Acad Sci U S A 1992;89:7674-7
61. Haddad IY, Crow J, Yoazu Y, Beckman S, Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A (SP-A). Am J Physiol (Lung Cell Mol Physiol) 1994;267:L242-L249.
62. Samama CM, Diaby M, Fellahi JL, et al. Inhibition of platelet aggregation by inhaled nitrioxide in patients with acute respiratory distress syndrome. Anesthesiology 1995;83:56-65.
63. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening or pulmonary gas exchange with nitric oxide in halation in chronic obstructive pulmonary disease. Lancet 1996;347:436-40.
64. Roger N, Barberá JA, Roca J, Rovira I, Gomez FP, Rodriguez-Roisin R. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:800-6.
65. Blanch L, Joseph D, Férnandez R, et al. Hemodynamic and gas exchange responses to inhalation of nitric oxide in patients with the acute respiratory distress syndrome and in hypoxemic patients with chronic obstructive pulmonary disease. Intensive Care Med 1997;23:31-7
66. Berisha H, Pakbaz H, Absood A, Said SI. Excess nitric oxide (NO) production in acute lung injury: role of constitutive vs inducible NO synthase [abstract]. Am J Respir Crit Care Med 1994;149:A552.
67. Garat C, Jayr C, Eddahibi S, Laffon M, Meignan M, Adnot S. Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med 1997;155:1957-64.
68. Body SC, Hartigan PM, Shernan SK, Formaneck V Hurford WE. Nitric oxide: delivery measurement and clinical application. J Cardiothorac Vasc Anesth 1995;9:748-63.
69. Lavoi A, Hall JB, Olson DM, Wylan ME. Life threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 1996;153:1985-7.
70. Marshall C, Marshall BE. Interpretation of the effects of inhaled nitric oxide in respiratory dysfunction. A self-teaching interactive program [abstract]. Anesthesiology 1998,88(Suppl):A80.